News

A study published in the latest edition of the journal PLOS Medicine used gene variant analysis to assess the association between modifiable risk factors and individual patient susceptibility to being diagnosed with Alzheimer’s Disease (AD).  The study, entitled “Associations between Potentially Modifiable Risk Factors…

Researchers at the Hospital de Magalhães Lemos and the Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto in Portugal recently revealed that a patient’s ability to cope with the neurodegenerative process in disorders like Alzheimer’s disease can influence disease severity. The study is entitled “…

Actinogen Limited, a biotechnology company focused on the treatment of Alzheimer’s Disease and mild cognitive impairment, a transitional stage of cognitive impairment between normal aging and the more serious conditions of Alzheimer’s and dementia, recently announced that it has received approval for the third and final stage of the second…

The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Stemedica Cell Technologies, Inc. The approval means that the company is allowed to initiate a phase 2a clinical study to evaluate the use of an allogeneic stem-cell therapy for…

Phoenix-based Banner Alzheimer’s Institute (BAI) was recently awarded a joint $10 million research funding grant from the Alzheimer’s Association, GHR Foundation and Fidelity Biosciences Research Initiative. The three organizations announced their plan to fund BAI’s efforts, given the organization’s reputation as an internationally recognized Alzheimer’s care and…

In a recent report published by Alzheimer’s Disease International (ADI), titled “Women and Dementia: A global research overview,” researchers reported on key findings regarding the main topics affecting women in relation to dementia from an international viewpoint. In the report, the ADI examined the gender effect in women living with dementia; women caring for people with dementia in a professional caring role; and…

In a recent study published in the Journal of Bodywork and Movement Therapies, researchers at Teesside University in the UK found that combining cognitive activities and elements of yoga, tai chi, qigong and meditation with routine physical exercise improves the quality of life of patients with dementia.

In a recent study published in the journal Behavioural Brain Research, researchers found that Cerebral dopamine neurotrophic factor (CDNF) can improve long-term memory in a mouse model of Alzheimer’s disease. Evidence has pointed to an important role of altered neurotrophic factor signaling in a wide array of…

Burlingame, California based mobile platform company Fanfare Entertainment has partnered with Muses Labs to help develop, optimize, and market a next-generation personalized combination therapy for treatment and prevention of Alzheimer’s disease. The MEND (metabolic enhancement for neurodegeneration) Protocol is designed to enable Alzheimer’s disease patients, their caregivers, family members, and…

A new drug developed at Lancaster University in the United Kingdom that might help to prevent early stages of Alzheimer’s disease and is about to enter clinical trials. The number of individuals affected by dementia is constantly increasing. According to estimates, there are 850,000 cases in the United Kingdom currently, with estimates that the number…